UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000018853
Receipt number R000021764
Scientific Title Pupil perimetry with colored stimuli in glaucoma
Date of disclosure of the study information 2015/09/10
Last modified on 2015/09/11 08:47:02

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Pupil perimetry with colored stimuli in glaucoma

Acronym

Pupil perimetry with colored stimuli in glaucoma

Scientific Title

Pupil perimetry with colored stimuli in glaucoma

Scientific Title:Acronym

Pupil perimetry with colored stimuli in glaucoma

Region

Japan


Condition

Condition

Glaucoma and normal eyes(No history of any disease that may cause visual disorder except for ametropia).

Classification by specialty

Ophthalmology Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the sensitivity of glaucomatous visual disorder detection by pupil perimetry with colored stimuli.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

To investigate the sensitivity and specificity of glaucomatous visual disorder detection by pupil perimetry with colored stimuli.
Index for evaluation is pupillary constriction ratio (magnitude of the light reflex).

Key secondary outcomes

To investigate the normal range of normal eyes of pupil perimetry with colored stimuli.


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Device,equipment

Interventions/Control_1

To measure 100 glaucomatous patients (200 eyes) by a pupil perimetry with colored stimuli.
To measure 100 non-glaucomatous patients by a pupil perimetry with colored stimuli.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. Primary open-angle glaucomatous, normal-tension glaucomatous patients and the suspicion.
2. Non-glaucomatous patients ( as a control group). No history of any disease that may cause visual disorder except for ametropia.
3. Subject who can be observed entrance pupil.
4. Subjects who sign an informed consent form to participate in the clinical study.

Key exclusion criteria

1. Eyes that a pupillary scan is difficult due to exfoliation and so on.
2. Disorder of an iris and the autonomic nervous system.
3.History of any disease that may cause visual disorder except for glaucoma (in glaucomatous group).
4. Disorder of the pupil movement due to senile miosis and so on.

Target sample size

200


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Keiichi Tanzawa

Organization

Kawasaki University of Medical Welfare

Division name

Department of Sensory Science

Zip code


Address

288, Matsushima, Kurashiki, Okayama

TEL

0864621111

Email

tanzawa@mw.kawasaki-m.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Keiichi Tanzawa

Organization

Kawasaki University of Medical Welfare

Division name

Department of Sensory Science

Zip code


Address

288, Matsushima, Kurashiki, Okayama

TEL

0864621111

Homepage URL


Email

tanzawa@mw.kawasaki-m.ac.jp


Sponsor or person

Institute

Kawasaki University of Medical Welfare

Institute

Department

Personal name



Funding Source

Organization

National Center for Geriatrics and Gerontrogy

Organization

Division

Category of Funding Organization

Nationality of Funding Organization

japan


Other related organizations

Co-sponsor

Saneikai Tsukazaki Hospital

Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

三栄会 ツカザキ病院 (兵庫県)


Other administrative information

Date of disclosure of the study information

2015 Year 09 Month 10 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2015 Year 09 Month 10 Day

Date of IRB


Anticipated trial start date

2015 Year 09 Month 10 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2015 Year 08 Month 30 Day

Last modified on

2015 Year 09 Month 11 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000021764


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name